Phase 3Not yet recruitingAge-related condition

Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee Osteoarthritis (ACCELERATE3)

Bone Marrow Aspirate ConCentrate for the Treatment of knEe Osteoarthritis: A Phase III, muLti-centER, Pan-cAnadian, prospecTivE Trial

Sponsor
CELL Technologies Inc. (Industry)
Enrollment
374 planned
Conditions
Knee Osteoarthritis; Musculoskeletal Diseases
Interventions
Autologous Bone Marrow Aspirate Concentrate
Ages
adults, older adults
Registry
NCT06216028

Full record on ClinicalTrials.gov

From the registry

The purpose of the ACCELERATE3 trial is to assess the efficacy of a single intra-articular (IA) injection of autologous BMAC, in one or both knees, compared to a single IA injection of Standard of Care (SOC) in patients with mild to severe knee OA.

Primary outcomes

  • WOMAC® Pain Subscore

History

  1. Study completion expected

  2. Primary completion

  3. Started

  4. Last registry update

  5. Registered